Skip to Main Content

Paper Details

In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium.
Stem Cell Reports
7
2022
OCA, OCA1A, OCA2, Oculocutaneous albinism, RPE, RPE cells, RPE tissue, abnormal decussation of, abnormalities in fovea development, albinism, autosomal recessive genetic conditions, human, human induced pluripotent stem cell, human induced pluripotent stem cell-derived retinal pigment epithelium, human retinal pigment epithelium, induced pluripotent stem cells, oculocutaneous albinism type 1 and 2, optic nerve fibers, patients, pigmentation defects, vision defects
Author NameAffiliation
Nathan HotalingNational Eye Institute, National Institutes of Health
Nathan HotalingNational Eye Institute, National Institutes of Health
David R AdamsOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
David R AdamsOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
  • 1 - 4

Datasets

Release 1.2